AGIOS PHARMACEUTICALS

Company

AGIOS PHARMACEUTICALS, INC.

Filed

February 6, 2014

Accession Number

0001072613-14-000051

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →